Project Grant R15DK128756
- This Project Grant award from the National Institute on Aging (NIA) under CFDA 93.866 - Aging Research will provide $314,000.00 over the period of May 1, 2025 to April 30, 2027 to the University of California, Irvine (UCI) to conduct research on the "Molecular Mechanisms Underlying Reduced Vitamin C Transport Process in Alzheimer's Disease and its Impact on Neuroinflammation". The project aims to investigate the underlying causes for vitamin C deficiency observed in Alzheimer's disease...
- The Trustees of Columbia University in the City of New York, through its Health Sciences Division, has been awarded a $294,000 Project Grant from the USDA National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) program. The grant will fund a 4-year study to test the effects of walnut consumption on blood melatonin levels and sleep quality in middle-aged to older adults with sleep difficulties. The study aims to provide evidence on the potential...
- The National Institute on Aging (NIA) awarded a $405,849 Project Grant (CFDA 93.866 - Aging Research) to the Keck Graduate Institute of Applied Life Sciences to investigate the impact of obesity-induced hepatic amyloid beta dysregulation on Alzheimer's disease pathology. The key objectives are to: Examine the relationship between changes in peripheral and hepatic amyloid beta with brain amyloid beta load and Alzheimer's disease pathology in Alzheimer's disease mice fed a high-fat/high-sugar...
- This $6,424,607 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to investigate the impact of Mediterranean vs. Western diet on cognitive function, and neurological biomarkers associated with Alzheimer's disease risk, in middle-aged male and female cynomolgus monkeys. The 4-year longitudinal study, awarded to Wake Forest University Health Sciences, aims to provide critical insight into the mechanisms by which diet composition can...
- This Project Grant award for $380,060 from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) supports research by the Arizona Veterans Research And Education Foundation, a non-profit organization, to evaluate anti-Medin immunotherapy for addressing vascular aging and related dementias. The project aims to develop and test the efficacy of an anti-Medin vaccine (Aim 1) as well as anti-Medin monoclonal antibodies (Aim 2) in preventing or attenuating...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $794,981 to the University of California, San Diego (UCSD) to investigate the use of blood-brain barrier permeability and brain microstructure as biomarkers for predicting and monitoring amyloid-related imaging abnormalities (ARIA) and treatment outcomes in Alzheimer's disease patients prescribed anti-amyloid immunotherapies. The study aims to integrate advanced MRI techniques into...
- This Project Grant award of $766,133 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to understand the mechanisms leading to amyloid-related imaging abnormalities (ARIA) that can occur with anti-amyloid immunotherapy for Alzheimer's disease. The research aims to: Determine the elimination pathway and clearance mechanism for chimeric anti-amyloid antibodies (ChAbs) in Alzheimer's disease mouse models. Examine how ARIA events develop in Alzheimer's disease...
- This $4,260,300 project grant from the National Institutes of Health's National Institute on Aging will fund research under the Aging Research program (CFDA 93.866) to investigate the association between in utero environmental exposures and life-course cognition and prodromal Alzheimer's disease in midlife. The Public Health Institute will leverage existing data and biospecimens from the 50+ year follow up of the Child Health and Development Studies birth cohort to conduct targeted and...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $462,923 to Albany Medical College to develop new mouse models of andropause (age-related decline in male sex hormones) for Alzheimer's disease and related dementia (ADRD) research. The primary goals are to: Determine the natural time course of endocrine aging in wild-type mice and mouse models of ADRD (Aim 1). Model endocrine aging in male mice via gonadectomy and gradual androgen...
- This three-year, $4.84 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research at The Johns Hopkins University to investigate the neurological effects and cumulative risk of neurodegenerative disease from exposure to metal mixtures. Specifically, the researchers will examine the biological mechanisms by which exposure to mixtures of lead, arsenic, cadmium, and chromium during adulthood and early development cause...
EFFECT OF ALMOND CONSUMPTION ON IRON STATUS IN INFLAMMATORY STATES - PROJECT SUMMARY/ABSTRACT ANEMIA OF INFLAMMATION (AI) IS THE SECOND MOST PREVALENT FORM OF ANEMIA. IT IS CAUSED BY CHRONIC INFLAMMATION ASSOCIATED WITH AGING AND CHRONIC DISEASES SUCH AS CANCER AND RHEUMATOID ARTHRITIS. WHILE PEOPLE WITH AI HAVE SUFFICIENT BODY IRON, INCREASED SEQUESTRATION DUE TO ELEVATED CONCENTRATION OF THE PROTEIN HEPCIDIN LEADS TO INSUFFICIENT CIRCULATING IRON FOR RED BLOOD CELL SYNTHESIS. AI IS ALSO EXACERBATED BY THE DESTRUCTION OF RED BLOOD CELLS (RBCS) BY MACROPHAGES DUE TO INFLAMMATION. UNFORTUNATELY, CURRENT THERAPIES, INCLUDING BLOOD TRANSFUSION, DO NOT REDUCE THE ELEVATED CONCENTRATIONS OF HEPCIDIN; FURTHERMORE, TRANSFUSION INCREASES RISK OF EXCESS IRON, WHICH CAN CAUSE ADVERSE EFFECTS. WHILE EXPERIMENTAL DRUGS TARGETING HEPCIDIN ARE BEING DEVELOPED, THEIR LONG- TERM ADVERSE EFFECTS ARE NOT KNOWN, WARRANTING NEW NON-PHARMACEUTICAL APPROACHES. OUR LONG-TERM GOAL IS TO IDENTIFY DIETARY APPROACHES FOR MITIGATING AI. CONSUMPTION OF ALMONDS MAY MITIGATE AI BY DIFFERENT MECHANISMS; THESE INCLUDE (I) REDUCING INFLAMMATION, (II) ALTERING THE GUT MICROBIOME COMPOSITION, AND (III) IMPROVING ROBUSTNESS OF RBCS BY INCREASING THEIR VITAMIN E CONTENT, WHICH PROTECTS THEM FROM OXIDATIVE DAMAGE. IN THIS PROPOSED R15 STUDY, WE WILL TEST THE OVERALL HYPOTHESIS THAT ALMOND CONSUMPTION WILL IMPROVE IRON STATUS IN INFLAMMATORY STATES, USING OBESE AND AGING MICE. WE CHOSE THESE MOUSE MODELS BECAUSE BOTH CONDITIONS ARE ASSOCIATED WITH INFLAMMATION, INCREASED HEPCIDIN, AND IMPAIRED IRON STATUS MARKERS. OUR PRELIMINARY 8-WEEK STUDY USING A MOUSE MODEL OF OBESITY PROVIDED SUGGESTIVE EVIDENCE THAT REGULAR ALMOND INTAKE REDUCED HEPCIDIN AND IMPROVED IRON CONCENTRATIONS IN PLASMA; HOWEVER, A LONGER-DURATION STUDY IS NEEDED FOR CONCLUSIVE EVIDENCE. OUR PROPOSED STUDY WILL INVESTIGATE THE EFFECTS OF A 24-WEEK HIGH-FAT DIET WITH ALMONDS (15% CALORIES FROM ALMONDS) ON CIRCULATING IRON CONCENTRATIONS IN C57BL/6 MICE. WE HYPOTHESIZE THIS TREATMENT WILL SIGNIFICANTLY IMPROVE IRON STATUS COMPARED TO HIGH-FAT AND LOW-FAT DIETS. WE WILL ALSO INVESTIGATE WHETHER THIS INTAKE OF ALMONDS CAN MITIGATE AGING-RELATED AI IN C57BL/6 MICE, A FREQUENTLY USED MODEL IN AGING RESEARCH. WE WILL FURTHER PROBE UNDERLYING MECHANISMS THAT MAY INFLUENCE THESE EFFECTS, INCLUDING CHANGES IN GUT MICROBIOTA COMPOSITION, HEPCIDIN CONCENTRATIONS, AND THE ANTIOXIDANT SYSTEM IN RBCS. IF OUR HYPOTHESES ARE BORNE OUT, WE WILL DEMONSTRATE THE POTENTIAL OF ALMONDS AS A DIETARY APPROACH TO MITIGATING AI. FURTHERMORE, THIS WORK WOULD BE THE FIRST TO ELUCIDATE THE CONTRIBUTIONS OF GUT MICROBIOTA AND RBC ANTIOXIDANT SYSTEM IN MITIGATING AI.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 7/25/25 | ||
| Not listed | $447.2k | 8/15/22 | ||
| Not listed | $447.2k | 8/15/22 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
A230062S003S | Health Research, Inc. | Project Grant R15DK128756 | $49.5k | 8/1/24 |